Pinnacle Research Group

Pinnacle Research Group is an established, privately-held clinical research site organization with over 24 years of operational history. It has built a strong reputation as a high-enrolling site, having completed over 500 trials with more than 5,000 participants, and maintains a specialized Phase I unit. The company serves as a critical partner to pharmaceutical sponsors and CROs, offering end-to-end trial management services from first-in-human studies to late-phase trials across numerous therapeutic areas. With a state-of-the-art facility and a focus on healthy volunteer and chronic condition populations, Pinnacle is positioned as a key player in the clinical trial execution ecosystem.

State-of-the-art dedicated clinical research facility featuring a 7,300 sq ft Phase I unit with 16 beds, full inpatient/outpatient capacity, and an on-site diagnostic suite (X-ray, ECG, ultrasound, DEXA) for integrated trial execution.

Pinnacle competes with other dedicated clinical research sites, site networks, and academic medical centers for sponsor contracts. Its differentiation is based on its long track record, specialized Phase I unit, and broad therapeutic expertise. Competition is intense on metrics of enrollment speed, data quality, and cost.